aim
studi
elucid
anticomplementari
principl
chines
multiherb
remedi
use
treatment
prevent
sar
contain
five
ingredi
herba
houttuynia
flo
chrysanthemi
indici
herba
artemisia
scoparia
herba
eupatorii
fructu
tsaoko
materi
method
anticomplementari
activ
evalu
hemolyt
assay
classic
pathway
cp
altern
pathway
ap
complement
system
vitro
compound
isol
use
bioactivityguid
fraction
test
vitro
complementinhibit
properti
cp
ap
hplcdadesim
use
assign
isol
compound
five
ingredi
herb
result
compound
includ
chlorogen
acid
rutin
hyperosid
phydroxyacephenon
scopoletin
quercitrin
acaciin
scoparon
luteolin
quercetin
apigenin
acacetin
aristolactam
dimethyl
ether
isol
identifi
nine
flavonoid
found
show
inhibitori
effect
toward
cp
ap
complement
system
luteolin
potent
ch
ap
valu
mm
bioactiv
flavonoid
mainli
deriv
herba
houttuynia
flo
chrysanthemi
indici
herba
artemisia
scoparia
conclus
chines
multiherb
remedi
use
treatment
prevent
sar
robust
inhibitori
effect
complement
system
cp
ap
anticomplementari
activ
could
attribut
flavonoid
present
ingredi
herb
luteolin
could
potenti
anticomplementari
agent
complement
system
play
crucial
role
elimin
invad
pathogen
gener
optim
host
respons
activ
cascad
mechan
classic
pathway
cp
altern
pathway
ap
lectin
pathway
carrol
fischer
howev
wealth
data
clearli
demonstr
undesir
activ
complement
respons
initi
amplif
perpetu
tissu
damag
inflamm
number
patholog
situat
morgan
harri
sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
sever
mortal
affect
mani
countri
coronaviru
etiolog
agent
peiri
et
al
term
pathogenesi
sar
viral
load
first
phase
may
turn
result
host
inflammatori
respons
second
phase
sar
complic
associ
sever
inflammatori
tissu
destruct
due
excess
activ
innat
immun
system
notabl
proport
patient
progress
septic
shock
acut
respiratori
distress
syndrom
ard
multipl
organ
dysfunct
mod
later
phase
viral
infect
li
et
al
consider
clinic
experiment
evid
implic
complement
appear
involv
pathogenesi
late
postvir
complic
could
even
predict
increas
complement
activ
sahu
lambri
abe
sarma
et
al
henc
antivir
agent
combin
inhibit
complement
cascad
reaction
may
repres
attract
effici
therapeut
strategi
sar
tradit
chines
medicin
tcm
play
import
role
fight
sar
report
practition
effect
lau
et
al
multiherb
remedi
contain
five
ingredi
herba
houttuynia
flo
chrysanthemi
indici
herba
artemisia
scoparia
herba
eupatorii
fructu
tsaoko
recommend
treatment
prevent
sar
state
administr
tcm
peopl
republ
china
accord
tcm
herba
houttuynia
flo
chrysanthemi
indici
herba
artemisia
scoparia
function
elimin
evilheat
detoxif
herba
eupatorii
fructu
tsaoko
commonli
use
dispers
damp
pharmacolog
experi
show
fiveingredi
herb
possess
direct
inhibitori
activ
viru
bacteria
inflamm
hayashi
et
al
sun
et
al
moon
et
al
xie
et
al
cheng
et
al
sinc
complement
inhibitori
agent
could
benefici
treatment
prevent
sar
medicin
plant
multiherb
remedi
assess
vitro
complementinhibit
properti
preliminari
studi
ethanol
extract
fiveherb
remedi
found
possess
reproduc
activ
cp
ap
complement
system
vitro
bioactivityguid
fraction
show
ethyl
acetatesolubl
fraction
signific
anticomplementari
activ
chromatograph
separ
activ
fraction
led
isol
compound
includ
flavonoid
coumarin
alkaloid
monoterpen
organ
acid
keton
flavonoid
found
show
signific
inhibitori
effect
toward
cp
ap
complement
system
addit
high
perform
liquid
chromatographi
coupl
diod
array
detector
electrospray
ionizationmass
spectrometri
hplcdadesim
appli
identifi
track
compound
ingredi
herb
isol
anticomplementari
activ
compound
hplcdadesim
analysi
report
herein
optic
rotat
measur
c
jasco
polarimet
methanol
esim
measur
agil
sl
singl
quadrupol
mass
spectromet
usa
equip
esi
sourc
h
mhz
c
mhz
nmr
spectra
record
bruker
drx
spectromet
cdcl
aceton
dmsod
solvent
chemic
shift
repres
ppm
highspe
refriger
centrifug
jouan
co
franc
spectrophotomet
wellscan
labsystem
dragon
use
assay
anticomplementari
activ
hplc
system
agil
technolog
seri
usa
consist
automat
sampler
injector
binari
pump
continu
vacuum
degass
column
heatercool
variabl
wavelength
diod
array
detector
agil
sl
singl
quadrupol
mass
spectromet
usa
equip
esi
sourc
oper
acquir
analysi
data
control
chemstat
softwar
agil
technolog
usa
plant
materi
purchas
shanghai
huayu
chines
matreria
medica
co
ltd
identifi
herba
houttuynia
aerial
part
houttuynia
cordata
thunb
saururacea
flo
chrysanthemi
indici
flower
chrysanthemum
indicum
l
composita
herba
artemisia
scoparia
aerial
part
artemisia
scoparia
waldst
et
kit
composita
herba
eupatorii
aerial
part
eupatorium
fortunei
turcz
composita
fructu
tsaoko
ripe
fruit
amomum
tsaoko
crevost
et
lemair
zingiberacea
one
author
dr
ting
zhang
voucher
specimen
deposit
depart
pharmacognosi
school
pharmaci
fudan
univers
shanghai
pr
china
silica
gel
precoat
tlc
obtain
qingdao
haiyang
chemic
factori
qingdao
china
sephadex
od
purchas
amersham
pharmacia
biotech
uppsala
sweden
acetonitril
hplc
grade
honeywel
usa
acet
acid
reagent
analyt
grade
shanghai
chemic
factori
shanghai
china
water
purifi
use
milliq
water
purif
system
millipor
usa
guinea
pig
new
zealand
white
rabbit
purchas
laboratori
anim
research
institut
fudan
univers
shanghai
china
anim
experi
conduct
accord
current
ethic
regul
anim
care
use
fudan
univers
normal
human
sera
nh
obtain
three
male
donor
healthi
blood
averag
age
year
rang
year
year
written
inform
consent
particip
studi
studi
receiv
approv
ethic
committe
fudan
univers
sheep
erythrocyt
collect
alsev
solut
purchas
shanghai
kangrun
biotech
co
ltd
antisheep
erythrocyt
antibodi
prof
yunyi
zhang
depart
pharmacolog
fudan
univers
shanghai
china
rabbit
erythrocyt
obtain
ear
vein
new
zealand
white
rabbit
serum
guinea
pig
nh
use
sourc
complement
cp
ap
respect
heparin
sodium
salt
iumg
purchas
shanghai
aizit
biotech
co
ltd
veron
buffer
salin
vb
ph
vb
contain
mm
mg
mm
ca
vb
vb
contain
mm
mg
mm
egta
vbsmgegta
prepar
describ
literatur
cp
ap
respect
nelson
et
al
herba
houttuynia
flo
chrysanthemi
indici
herba
artemisia
scoparia
herba
eupatorii
fructu
tsaoko
pulver
mix
well
ratio
weight
dri
herb
accord
instruct
state
administr
tcm
pr
china
mixtur
kg
extract
etoh
l
room
temperatur
remov
etoh
reduc
pressur
afford
dark
green
residu
g
residu
suspend
water
ml
success
partit
petroleum
ether
c
etoac
nbuoh
ml
give
three
extract
g
g
g
respect
highest
anticomplementari
activ
observ
etoac
extract
accord
result
hemolyt
assay
cp
ap
use
biolog
activ
guid
tabl
etoacsolubl
fraction
g
subject
column
chromatographi
silica
gel
mesh
g
elut
gradient
petroleum
etheraceton
ml
eluent
yield
six
fraction
ivi
fraction
ii
g
subject
column
chromatographi
silica
gel
mesh
petroleum
etheraceton
prepar
tlc
silica
gf
petroleum
etheraceton
give
compound
mg
mg
mg
fraction
iii
g
subject
column
chromatographi
silica
gel
mesh
petroleum
etheraceton
sephadex
chloroformmethanol
yield
compound
mg
mg
mg
mg
fraction
iv
g
chromatograph
silica
gel
mesh
column
chloroformmethanol
sephadex
column
chloroformmethanol
column
methanolwat
provid
compound
mg
mg
mg
fraction
v
g
load
column
chromatographi
silica
gel
mesh
chloroformmethanol
sephadex
chloroformmethanol
methanolwat
prepar
tlc
silica
gf
chloroformmethanol
give
compound
mg
mg
purif
fraction
vi
g
silica
gel
mesh
chloroformmethanol
sephadex
chloroformmethanol
methanolwat
methanolwat
column
chromatographi
prepar
tlc
silica
gf
chloroformmethanol
afford
compound
mg
mg
mg
puriti
compound
determin
normal
peak
area
detect
hplc
dad
chromatograph
condit
describ
section
assay
base
haemolysi
erythrocyt
membran
gener
complement
activ
base
mayer
modifi
method
kabat
mayer
sensit
erythrocyt
ea
prepar
incub
sheep
erythrocyt
cellsml
rabbit
antisheep
erythrocyt
antibodi
vb
compound
dissolv
dmso
dilut
vb
final
concentr
dmso
dilut
variou
concentr
assay
lysi
l
ea
l
water
incub
provid
differ
assay
control
reaction
mixtur
centrifug
immedi
l
supernat
transfer
flatbottom
micropl
optic
densiti
measur
nm
anticomplementari
activ
determin
mean
triplic
test
per
concentr
express
inhibitori
concentr
ch
valu
complementdepend
haemolysi
control
heparin
sodium
salt
polyanion
glycosaminoglycan
use
posit
control
activ
complement
ap
measur
ca
free
condit
accord
klerx
method
klerx
et
al
vbsmgegta
use
buffer
medium
assay
compound
dissolv
dmso
dilut
vbsmgegta
final
concentr
dmso
dilut
variou
concentr
assay
dilut
nh
chosen
give
submaxim
lysi
absenc
complement
inhibitor
preincub
dilut
sampl
l
dilut
nh
l
c
min
residu
complement
mixtur
measur
term
haemolysi
l
rabbit
erythrocyt
er
cellsml
control
sampl
control
lysi
control
extract
blank
lysi
includ
anticomplementari
activ
express
inhibitori
concentr
ap
valu
heparin
sodium
salt
use
posit
control
fiveingredi
herb
individu
dri
pulver
approxim
g
pulver
sampl
accur
weight
extract
twice
min
ml
methanol
ultrason
bath
combin
solut
evapor
dryness
residu
dissolv
ml
flask
methanol
result
solut
filter
syring
filter
store
c
l
hplcdadesim
analysi
lc
separ
perform
column
mm
mm
phenomenex
luna
usa
temperatur
c
binari
mobil
phase
consist
aqueou
acet
acid
acetonitril
b
solvent
filter
nylon
filter
prior
use
flowrat
kept
constantli
mlmin
total
run
time
min
outflow
firstli
enter
dad
subsequ
enter
ms
detector
gradient
elut
program
use
accord
follow
profil
min
b
min
b
min
hold
b
sampl
inject
volum
l
dad
detector
set
nm
nm
refer
wavelength
nm
bandwidth
full
spectral
scan
nm
nm
resolut
ms
use
two
channel
detect
analysi
posit
mode
condit
ms
analysi
follow
dri
ga
n
flowrat
lmin
dri
ga
temperatur
c
nebul
ga
n
pressur
psi
capillari
voltag
kv
full
scan
rang
mz
fragment
v
standard
compound
extract
sampl
analyz
select
ion
monitor
sim
mode
use
esi
sourc
monitor
proton
molecular
ion
analyt
select
ion
monitor
compound
restrict
specif
molecular
weight
mz
channel
mz
channel
ethanol
extract
show
anticomplementari
activ
ch
ap
valu
mgml
result
haemolysi
sheep
rabbit
erythrocyt
higher
concentr
mgml
respect
bioactivityguid
fraction
indic
petroleum
ether
fraction
result
haemolysi
sheep
rabbit
erythrocyt
higher
concentr
mgml
respect
accord
result
lysi
control
without
serum
ethanol
extract
petroleum
ether
fraction
definit
induc
lysi
dose
assay
exceedingli
larg
etoac
nbuoh
fraction
inhibit
cp
ap
complement
system
dosedepend
manner
etoac
fraction
show
pronounc
complement
inhibit
nbuoh
fraction
measur
diminish
haemolysi
sensit
erythrocyt
presenc
complement
factor
fig
tabl
thu
conclud
main
anticomplementari
principl
enrich
etoac
fraction
chromatograph
separ
etoac
fraction
yield
compound
structur
elucid
chlorogen
acid
pauli
et
al
rutin
et
al
hyperosid
wang
et
al
phydroxyacephenon
kai
et
al
scopoletin
sun
et
al
quercitrin
wang
et
al
maria
cesar
acaciin
park
et
al
scoparon
tsukamoto
et
al
luteolin
miyazawa
hisama
quercetin
miyazawa
hisama
apigenin
miyazawa
hisama
acacetin
miyazawa
hisama
aristolactam
kim
et
al
dimethyl
ether
li
et
al
basi
uv
ms
hnmr
cnmr
spectral
data
fig
compound
test
anticomplementari
activ
vitro
result
obtain
summar
tabl
nine
flavonoid
show
higher
inhibitori
effect
toward
cp
ap
complement
system
compound
phydroxyacephenon
keton
aristolactam
alkaloid
weakli
activ
cp
inact
ap
chlorogen
acid
organ
acid
scopoletin
coumarin
scoparon
coumarin
monoterpen
inhibitori
effect
toward
cp
ap
cp
complement
system
luteolin
found
strong
anticomplementari
activ
ch
valu
mm
rutin
quercitrin
quercetin
moder
activ
hyperosid
acaciin
apigenin
acacetin
dimethyl
ether
exhibit
weak
activ
assay
system
ap
complement
system
rutin
hyperosid
quercitrin
luteolin
show
higher
activ
ap
valu
less
mm
follow
quercetin
apigenin
acaciin
acacetin
dimethyl
ether
complet
inact
flavonoid
found
activ
principl
variou
medicin
plant
inflammatori
diseas
consid
good
sourc
kind
inhibitor
complement
system
flavonoid
morinda
morindoid
cimanga
et
al
olea
europaea
l
pieroni
et
al
centaurium
spicatum
shahat
et
al
present
studi
flavonoid
found
main
anticomplementari
constitu
fiveherb
remedi
treatment
prevent
sar
luteolin
potent
could
serv
potenti
anticomplementari
agent
worthi
mention
pathogenesi
symptom
avian
influenza
similar
sar
ku
chan
jong
hien
henc
inhibit
complement
system
could
also
effici
therapeut
strategi
human
avian
influenza
studi
natur
occur
inhibitor
complement
system
would
provid
great
prospect
develop
novel
drug
treatment
prevent
sar
avian
influenza
particularli
tradit
chines
medicin
owe
chemic
complex
divers
multiherb
remedi
analyt
method
hplc
coupl
dad
esim
use
simultan
identif
compound
fiveingredi
herb
acet
acid
use
mobil
phase
modifi
significantli
restrain
peak
tail
phenol
compound
baselin
separ
target
compon
achiev
within
min
use
simpl
gradient
elut
programm
fig
c
posit
mode
select
ms
spectra
obtain
esi
singl
stage
mass
simpl
stabl
easi
interpret
quasimolecular
ion
typic
correspond
base
peak
lower
fragment
voltag
v
select
gener
rare
fragment
pattern
chromatograph
condit
describ
proton
molecular
ion
mh
could
detect
compound
select
ion
monitor
sim
sensit
specif
full
scan
employ
detect
compound
typic
posit
esi
mass
spectra
compound
shown
fig
e
well
retent
time
r
proton
molecular
ion
summar
tabl
tabl
retent
time
r
esim
data
posit
ion
mode
mz
compound
newli
develop
hplcdadm
assay
subsequ
appli
simultan
identif
compound
fiveingredi
herb
repres
chromatogram
five
herb
shown
fig
compound
analyz
sampl
identifi
compar
retent
time
uv
spectra
ms
data
obtain
refer
substanc
fig
tabl
well
spike
sampl
refer
compound
analysi
confirm
presenc
compound
herba
houttuynia
differ
content
compound
detect
flo
chrysanthemi
indici
compound
found
herba
artemisia
scoparia
meanwhil
compound
compound
could
detect
herba
eupatorii
fructu
tsaoko
respect
tabl
accord
literatur
haruna
et
al
chu
et
al
xie
et
al
jiang
gao
xu
et
al
plenti
flavonoid
present
herba
houttuynia
flo
chrysanthemi
indici
herba
artemisia
scoparia
sesquiterpen
monoterpen
distribut
herba
eupatorii
good
agreement
result
hplcdadm
analysi
although
report
flavonoid
obtain
fructu
tsaoko
sever
flavonoid
detect
methanol
extract
fructu
tsaoko
ms
detector
sim
mode
investig
therefor
isol
nmr
elucid
would
help
confirm
presenc
flavonoid
fructu
tsaoko
result
hplcdadm
analysi
found
flavonoid
deriv
herba
houttuynia
flo
chrysanthemi
indici
herba
artemisia
scoparia
mainli
respons
inhibitori
effect
investig
multiherb
remedi
complement
system
studi
demonstr
fiveherb
remedi
use
treatment
prevent
sar
robust
inhibitori
effect
complement
system
cp
ap
anticomplementari
activ
remedi
could
attribut
flavonoid
present
ingredi
herb
luteolin
could
potenti
anticomplementari
agent
high
activ
potenc
extens
abund
medicin
plant
present
studi
provid
import
basi
medic
applic
bioactiv
extract
compound
treatment
inflammatori
diseas
associ
inappropri
activ
complement
system
howev
pharmacolog
toxicolog
studi
necessari
confirm
specul
